Targeting CXCR4 Abrogates Resistance to Trastuzumab by Blocking Cell Cycle Progression and Synergizes with Docetaxel in Breast Cancer Treatment
Breast Cancer Research(2023)
Key words
Breast cancer,HER2,Drug resistance,CXCR4,Trastuzumab,Docetaxel,Targeted therapy,Combined therapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined